Real-world efficacy and safety of anlotinib combined with chemotherapy for advanced pancreatic cancer: a retrospective study
The data generated suggest that anlotinib combined with chemotherapy may be an effective and tolerable option for second-line and subsequent treatment of advanced PC.
Authors
- Hexia Gan
- Zhiming Wang (ORCID: https://orcid.org/0000-0002-0201-8912)
- Zhiyong Li (ORCID: https://orcid.org/0000-0002-1309-7732)
- Feng Shen
- Xiuping Zhang (ORCID: https://orcid.org/0000-0002-8117-2925)
- Li-Sha Cheng
Institutions
- Precision for Medicine (United States) (US)
- Zhongshan Hospital of Xiamen University (CN)
Publication Details
- Journal
- Future Science OA
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1080/20565623.2025.2532327
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Natural Science Foundation of Xiamen City
- Medical Innovation Project of Fujian Province